2021年05月25日
News Alert: Moderna says its coronavirus vaccine triggers immune response in teens ages 12 to 17; company will seek FDA authorization next month
The Washington Post
News Alert
May 25, 8:48 a.m. EDT
Moderna says its coronavirus vaccine triggers immune response in teens ages 12 to 17; company will seek FDA authorization next month
Biotechnology company Moderna announced Tuesday that its two-shot coronavirus vaccine produced the same immune response in teenagers as adults, and it plans to submit the data to U.S. regulators in early June.
If authorized, the vaccine would become the second available for adolescents as young as 12. Pfizer-BioNTech’s vaccine was authorized for that age group earlier this month.
Courtesy of The Washington Post
Cambridge Dictionary Search Boxをご用意しましたので、英単語の検索にご利用ください。
Courtesy of Cambridge Dictionary
News Alert
May 25, 8:48 a.m. EDT
Moderna says its coronavirus vaccine triggers immune response in teens ages 12 to 17; company will seek FDA authorization next month
Biotechnology company Moderna announced Tuesday that its two-shot coronavirus vaccine produced the same immune response in teenagers as adults, and it plans to submit the data to U.S. regulators in early June.
If authorized, the vaccine would become the second available for adolescents as young as 12. Pfizer-BioNTech’s vaccine was authorized for that age group earlier this month.
Courtesy of The Washington Post
Cambridge Dictionary Search Boxをご用意しましたので、英単語の検索にご利用ください。
Courtesy of Cambridge Dictionary
【このカテゴリーの最新記事】
-
no image
-
no image
-
no image
-
no image
-
no image
この記事へのコメント
コメントを書く
この記事へのトラックバックURL
https://fanblogs.jp/tb/10988115
※ブログオーナーが承認したトラックバックのみ表示されます。
この記事へのトラックバック
